Table 1.

Baseline immunological and virological characteristics of the study population

Category		Total HIV Subjects	IC1	IC2	IC3	Control
N a		62	20	33 (4) b	9 (5) b	20
Age c		7 (0.9 – 13)	7(0.9 – 13)	6(1.5 – 12)	6 (3 – 13)	7 (1 – 12)
VL (Log 10)c copies / ml		4.96 (3.65 – 5.87)	4.7 (3.65 – 5.88)	4.97 (3.75 – 5.88)	5.32 (4.73 – 5.69)	--
Hemoglobin (gm/dl) d		10.96 ± 1.4	10.73 ± 1.45	10.96 ± 1.51	11.19 ± 1.23	10.51 ± 1.30
CD3 d	%	79 ± 10	79 ± 8	78 ± 7	81 ± 14	66 ± 10
	Cells/mm3	2878 ± 1439	2954 ± 1079	2899 ± 1374	2780 ± 1864	4131 ± 2791
CD4 d	%	21 ± 4	32 ± 5	21 ± 3	9 ± 3	33 ± 8
	Cells/mm3	766 ± 374	1213 ± 530	809 ± 459	275 ± 132	2147 ± 1452
CD8 d	%	53 ± 10	42 ± 8	51 ± 8	66 ± 14	29 ± 10
	Cells/mm3	1909 ± 1041	1557 ± 578	1885 ± 883	2286 ± 1661	1764 ±1 446
CD19 d	%	10 ± 6	12 ± 7	11 ± 5	8 ± 5	23 ± 8
	Cells/mm3	388 ± 335	459 ± 375	465 ± 450	240 ± 179	1338 ± 939
CD16+56 d	%	17 ± 4	5 ± 3	7 ± 6	5 ± 4	9 ± 5
	Cells/mm3	220 ± 197	193 ± 130	306 ± 313	161 ± 149	485 ± 389
DC d	%	0.36 ± 0.03	0.31 ± 0.13	0.38 ± 0.28	0.40 ± 0.14	0.67 ± 0.32
	Cells/mm3	31 ± 2	27 ± 14	31 ± 17	33 ± 18	86 ± 66
mDC d	%	0.26 ± 0.02	0.24 ± 0.09	0.26 ± 0.20	0.28 ± 0.09	0.44 ± 0.20
	Cells/mm3	22 ± 2	21 ± 11	22 ± 13	23 ± 12	57 ± 43
pDC d	%	0.1 ± 0.01	0.07 ± 0.05	0.12 ± 0.10	0.12 ± 0.07	0.23 ± 0.14
	Cells/mm3	9 ± 1	6 ± 4	10 ± 6	10 ± 7	29 ± 24

^aN - Number of samples

^bValues in the brackets – Number of children initiated HAART

^cData are median (range)

^dData are mean ± SD